Boothbay Fund Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,534
Closed -$117K 1545
2025
Q1
$117K Buy
+20,534
New +$209K ﹤0.01% 1218
2024
Q4
Sell
-66,030
Closed -$566K 1615
2024
Q3
$538K Buy
66,030
+60,149
+1,023% +$603K 0.02% 950
2024
Q2
$78.6K Buy
5,881
+4,906
+503% +$146K ﹤0.01% 1372
2024
Q1
$45.2K Buy
975
+225
+30% +$11.6K ﹤0.01% 1479
2023
Q4
$50.7K Sell
750
-143
-16% -$8.76K ﹤0.01% 1522
2023
Q3
$64.7K Buy
893
+11
+1% +$879 ﹤0.01% 1608
2023
Q2
$65.6K Hold
882
﹤0.01% 1659
2023
Q1
$46.9K Buy
882
+257
+41% +$16.3K ﹤0.01% 2027
2022
Q4
$42.3K Buy
+625
New +$57.5K ﹤0.01% 1888
2022
Q3
Sell
-850
Closed -$81K 2328
2022
Q2
$81K Sell
850
-5,160
-86% -$629K ﹤0.01% 2019
2022
Q1
$969K Buy
6,010
+5,610
+1,403% +$1.09M 0.03% 927
2021
Q4
$133K Buy
+400
New +$190K ﹤0.01% 1647

Other funds holding DNA